Foroozan Rod
Baylor College of Medicine, 1977 Butler Boulevard, Houston, TX 77030, USA.
Neurol Clin. 2017 Feb;35(1):1-15. doi: 10.1016/j.ncl.2016.08.003.
Despite increasing knowledge about the risk factors and clinical findings of nonarteritic anterior ischemic optic neuropathy (NAION), the treatment of this optic neuropathy has remained limited and without clear evidence-based benefit. Historical treatments of NAION are reviewed, beginning with the Ischemic Optic Neuropathy Decompression Trial. More recent treatments are placed within the historical context and illustrate the need for evidence-based therapy for ischemic optic neuropathy.
尽管对非动脉炎性前部缺血性视神经病变(NAION)的危险因素和临床发现的认识不断增加,但这种视神经病变的治疗仍然有限,且缺乏明确的循证医学益处。本文回顾了NAION的既往治疗方法,从缺血性视神经病变减压试验开始。将近期的治疗方法置于历史背景中,以说明缺血性视神经病变循证治疗的必要性。